Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07113834) titled 'Characteristics of Ankylosing Spondylitis Associated Uveitis' on Aug. 3.
Study Type: Observational
Primary Sponsor: Benha University
Condition:
Uveitis
Intervention:
Drug: Adalimumab
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2023
Target Sample Size: 22
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07113834
Published by HT Digital Content Services with permission from Health Daily Digest....